Singulex has appointed Peter Heseltine as chief medical officer.
Heseltine is professor of Clinical Medicine at the University of California, Irvine. Previously he was senior vice president and chief medical officer at Prometheus Laboratories. He also held executive positions at Beckman Coulter and Quest Diagnostics.
ProteoMedix has named Mark Emberton as a clinical advisor.
Emberton is director of the Division of Surgery and Interventional Science at University College, London as well as a founding partner of London Urology Associates.